Use of coaching and technology to improve blood pressure control in Black women with hypertension: Pilot randomized controlled trial study.

Publication Year: 2022

DOI:
10.1111/jch.14617

PMCID:
PMC9832234

PMID:
36537265

Journal Information

Full Title: J Clin Hypertens (Greenwich)

Abbreviation: J Clin Hypertens (Greenwich)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors have no conflicts of interest to disclose."

Evidence found in paper:

"The authors thank the women who agreed to participate in this study. Funding source was the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K01HL140288. This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the United States Department of Veterans Affairs."

Evidence found in paper:

"For out‐of‐office BP monitoring, ambulatory BP is the reference standard. Research suggests that manual (auscultatory) BP taken according to American Heart Association recommendations by a well‐trained researcher is a strong predictor of ambulatory BP without white coat bias. In this study, a trained registered nurse measured the BP with a Welch Allyn Tycos (DS58) hand aneroid sphygmomanometer using recommended BP measurement guidelines., After individuals were seated for 5 min, three consecutive BP measurements were taken, 1 min apart and averaged to determine study eligibility. In addition to the baseline BP, weight was measured using a portable platform Seca 813 electronic scale and height was measured using a portable Seca 217 stadiometer. All details are reported elsewhere. Blood pressure and weight were repeated during months 1–3 to compare the referent group with usual care to the treatment group with ITEC. No baseline data were collected for steps, medication adherence, or dietary intake (calories/sodium) in either group. For both groups, manual BP and weight measurements were obtained in‐person at 3‐, 6‐, and 9‐months to verify data from the wireless tools. In‐person visits provided an opportunity to monitor data accuracy, check equipment, troubleshoot problems, and provide a human element to the study. Clinical Trial Registration: ClinicalTrials.gov Identifier NCT0357799."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025